Clinical trial
A Double-blind, Crossover, Placebo-controlled Study to Compare the Effects of Nighttime Administration of Suvorexant in Patients With Multiple Sclerosis Fatigue and Insomnia
NCT03110315 is registered in ClinicalTrials.gov with Theodore R. Brown, MD MPH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind, Crossover, Placebo-controlled Study to Compare the Effects of Nighttime Administration of Suvorexant in Patients With Multiple Sclerosis Fatigue and Insomnia
- Lead sponsor
- Theodore R. Brown, MD MPH
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 28, 2017
- Completion date
- March 21, 2022
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fatigue, insomnia, multiple sclerosis